Abstract
The purpose of this chapter is to review the literature on the relationship between attention-deficit-hyperactivity-disorder (ADHD) and binge eating as seen in bulimia nervosa (BN) and binge eating disorder (BED), including the shared phenomenology, genetics and treatment. The authors reviewed all the published peer reviewed literature in the past decade available through PubMed on the epidemiology, phenomenology, genetics and management of binge eating behavior, especially as it manifests in eating disorders (BN, BED), as well as in obesity and within the context of ADHD throughout the lifespan. It was found that there is a significant association between ADHD and binge eating in clinical populations. Inattentiveness and impulsivity noted in ADHD are thought to play a role in the preoccupations, urges and impulsive behaviors of those who experience binge-eating episodes. Molecular genetic studies have also identified common genes involved in dopamine transport, suggesting a shared genetic predisposition to binge eating, obesity and ADHD. Case reports on individuals with BN and ADHD suggest benefit from psychostimulant medication. In addition, other anti-ADHD medications such as atomoxetine have been used independently in trials to treat obesity and BED. Individuals with current symptoms or a past history of ADHD are at risk of having coexisting binge eating and obesity. Screening for ADHD in patients with binge-eating behaviors may identify individuals who could benefit from anti-ADHD medications. Further research may help to identify shared neurobiological mechanisms and particular risk factors, as well as to determine the efficacy and tolerability of certain medications in this population.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: American Psychiatric Association; 2000.
Agranat-Meged AN, Deitcher C, Goldzweig G, Leibenson L, Stein M, Galili-Weisstub E. Childhood obesity and attention deficit/hyperactivity disorder: a newly described comorbidity in obese hospitalized children. Int J Eat Disord. 2005;37:357–9.
Altfas JR. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry. 2002;13(2):9.
Bazar KA, Yun AJ, Lee PY, Daniel SM, Doux JD. Obesity and ADHD may represent different manifestations of a common environmental oversampling syndrome: a model for revealing mechanistic overlap among cognitive, metabolic, and inflammatory disorders. Med Hypotheses. 2006;66:263–9.
Cortese S, Bernardina BD, Mouren MC. Attention-deficit/hyperactivity disorder (ADHD) and binge eating. Nutr Rev. 2007;65:404–11.
Cortese S, Isnard P, Dalla Bernardina B, Mouren MC. Attention-deficit/hyperactivity disorder, binge eating, and obesity. J Clin Psychiatry. 2007;68:976; author’s reply 976–7.
Cortese S, Isnard P, Frelut ML, Michel G, Quantin L, Guedeney A, et al. Association between symptoms of attention-deficit/hyperactivity disorder and bulimic behaviors in a clinical sample of severely obese adolescents. Int J Obes (Lond.). 2007;31:340–6.
Davis C, Levitan RD, Smith M, Tweed S, Curtis C. Associations among overeating, overweight, and attention deficit/hyperactivity disorder: a structural equation modeling approach. Eat Behav. 2006;7:266–74.
Ersson G, Klanger AR, Wallsten T, Nilsson KW, Lindstrom L. Possible connection between eating disorders and ADHD. Bulimia can relieve ADHD symptoms, central nervous stimulants are of good help. Lakartidningen. 2007;104:1402–5.
Fleming J, Lance L. ADHD and disordered eating. In: Quinn P, Nadeau K, eds. Gender issues and ADHD: research, diagnosis, and treatment: Advantage Books; 2002.
Holtkamp K, Konrad K, Muller B, Heussen N, Herpertz S, Herpertz-Dahlmann B, et al. Overweight and obesity in children with Attention-Deficit/Hyperactivity Disorder. Int J Obes Relat Metab Disord. 2004;28:685–9.
Surman CB, Randall ET, Biederman J. Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case-control studies. J Clin Psychiatry. 2006;67:351–4.
Faraone SV, Biederman J, Spencer T, Mick E, Murray K, Petty C, et al. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry. 2006;163:1720–9.
Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007;61:348–58.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–55.
Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who’s paying? Health Aff. (Millwood) 2003;Suppl Web Exclusives (W3):219–26.
Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. An overview. Ann NY Acad Sci. 2001;931:1–16.
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the united states: results from the national comorbidity survey replication. Am J Psychiatry. 2006;163:716–23.
Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C, et al. Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology. 2007;32:2199–206.
Curtin C, Bandini LG, Perrin EC, Tybor DJ, Must A. Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: a chart review. BMC Pediatr. 2005;5:48.
Biederman J, Ball SW, Monuteaux MC, Surman CB, Johnson JL, Zeitlin S. Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. J Dev Behav Pediatr. 2007;28:302–7.
Mattos P, Saboya E, Ayrao V, Segenreich D, Duchesne M, Coutinho G. Comorbid eating disorders in a Brazilian attention-deficit/hyperactivity disorder adult clinical sample. Rev Bras Psiquiatr. 2004;26:248–50.
Levy F, Hay DA, Bennett KS, McStephen M. Gender differences in ADHD subtype comorbidity. J Am Acad Child Adolesc Psychiatry. 2005;44:368–76.
Sokol MS, Gray NS, Goldstein A, Kaye WH. Methylphenidate treatment for bulimia nervosa associated with a cluster B personality disorder. Int J Eat Disord. 1999;25:233–7.
Schweickert LA, Strober M, Moskowitz A. Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report. Int J Eat Disord. 1997;21:299–301.
Dukarm CP. Bulimia nervosa and attention deficit hyperactivity disorder: a possible role for stimulant medication. J Women’s Health (Larchmt). 2005;14:345–50.
Levitan RD, Masellis M, Basile VS, Lam RW, Kaplan AS, Davis C, et al. The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol Psychiatry. 2004;56:665–9.
Kaplan AS, Levitan RD, Yilmaz Z, Davis C, Tharmalingam S, Kennedy JL. A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa. Int J Eat Disord. 2008;41:22–8.
Kaplan AS, Levitan R, Tharmalingam S, Yilmaz Z, Kennedy J. Bulimia Nervosa and ADHD: Shared phenomenology, psychometrics and genetics. Presented at the annual meeting of the Eating Disorder Research Society, Oct 2007, Pittsburgh Pa.
Shinohara M, Mizushima H, Hirano M, Shioe K, Nakazawa M, Hiejima Y, et al. Eating disorders with binge-eating behavior are associated with the s allele of the 3’-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci. 2004;29:134–7.
Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem. 1995;65:1157–65.
Gornick MC, Addington A, Shaw P, Bobb AJ, Sharp W, Greenstein D, et al. Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): an update. Am J Med Genet B. Neuropsychiatr Genet 2007;144:379–82.
Elia J, Devoto M. ADHD genetics: 2007 update. Curr Psychiatry Rep. 2007;9:434–9.
Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ. Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord. 2002;6(Suppl. 1):S31–43.
Stein MA, Waldman ID, Sarampote CS, Seymour KE, Robb AS, Conlon C, et al. Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology. 2005;30:1374–82.
McElroy S, Hudson J, Ferreira-Cornwell C, et al. Lisdexafetamine dimesylate for adults with modertae to severe binge eating disorder: results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology. 2015;4:1251–1260.
Drimmer EJ. Stimulant treatment of bulimia nervosa with and without attention-deficit disorder: three case reports. Nutrition. 2003;19:76–7.
Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67:524–40.
Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemela A, Trott GE, et al. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2008;63:981–9.
Ong YL, Checkley SA, Russell GF. Suppression of bulimic symptoms with methylamphetamine. Br J Psychiatry. 1983;143:288–93.
Leddy JJ, Epstein LH, Jaroni JL, Roemmich JN, Paluch RA, Goldfield GS, et al. Influence of methylphenidate on eating in obese men. Obes Res. 2004;12:224–32.
Gadde KM, Yonish GM, Wagner HR 2nd, Foust MS, Allison DB. Atomoxetine for weight reduction in obese women: a preliminary randomized controlled trial. Int J Obes (Lond.). 2006;30:1138–42.
McElroy SL, Guerdjikova A, Kotwal R, Welge JA, Nelson EB, Lake KA, et al. Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial. J Clin Psychiatry. 2007;68:390–8.
Gadde KM, Yonish GM, Wagner HR 2nd, Foust MS, Allison DB. Atomoxetine for weight reduction in obese women: a preliminary randomized controlled trial. Int J Obes (Lond.). 2006;30:1138–42.
Goksoyr PK, Nottestad JA. The burden of untreated ADHD among adults: The role of stimulant medication. Addict Behav. 2008;33:342–6.
Davidson MA. ADHD in adults: A review of the literature. J Atten Disord. 2007;11:628–41.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kaplan, A.S., Howlett, A.L., Yilmaz, Z., Levitan, R. (2016). The Relationship Between Binge Eating and Attention Deficit Hyperactivity Disorder. In: Latzer, Y., Stein, D. (eds) Bio-Psycho-Social Contributions to Understanding Eating Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-32742-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-32742-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32740-2
Online ISBN: 978-3-319-32742-6
eBook Packages: MedicineMedicine (R0)